Number | Title | Author year Country | Species | Strain | Sex | Model | Stem cell type | Stem cell source | Compatibility SC-EVs Dose | SC-EVs dose units | Extraction method | Time of delivery | SC-EVs route | Follow-up |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke | Lee et al. (2015) Republic of Korea [22] | Rats | Sprague–Dawley | Male | MCAO | MSC | Adipose tissues, Xenogenic | 0.2 mg/kg | Dosed by weight of animal | DC | 48 h after pMCAO | IA | 7 days |
2 | MiR-17–92 cluster in exosomes enhance neuroplasticity and functional recovery after stroke in rats | Xin et al. (2018) USA [23] | Rats | Wistar | Male | MCAO | MSC | Bone marrow, Allogeneic | 100 μg total exosome protein into 0.5 ml PBS | Protein amount | DC | 24 h after MCAO | IV | 28 days |
3 | Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25 | Kuang et al. (2019) Germany [24] | Mice | C57BL/6 | Male | MCAO | MSC | Adipose tissue, Allogeneic | 200 μl of PBS corresponding to 10 μg of EVs | Protein amount | PEG | 12 h after tMCAO | IV | 14 days |
4 | In vivo Monitoring and Assessment of Exogenous Mesenchymal Stem Cell-Derived Exosomes in Mice with Ischemic Stroke by Molecular Imaging | Xu et al. (2020) China [25] | Mice | C57BL/6 | Male | A photothrombotic model of ischemic stroke | MSC | Bone marrow, Allogeneic | 100 μg, 200 μL PBS | Protein amount | DC | 0 h | IV | 14 days |
5 | miR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury | Pan et al. (2020) China [26] | Mice | C57BL/6 | Not reported | MCAO | MSC | Bone marrow, Allogeneic | 1 × 10^10 particles/100 μL in PBS | Particle number | DC | 48 h after tMCAO | IV | 2 days |
6 | Exosomes Derived from CXCR4-Overexpressing BMSC Promoted Activation of Microvascular Endothelial Cells in Cerebral Ischemia/Reperfusion Injury | Li et al. (2020) China [27] | Rats | SD | Male | MCAO | MSC | Bone marrow, Allogeneic | 100 μg | Protein amount | DC | 24 h after MCAO | ICV | 21 days |
7 | Exosomes treatment mitigates ischemic brain damage but does not improve post-stroke neurological outcome | Nalamolu et al. (2020) USA [28] | Rats | Sprague–Dawley | Male | MCAO | MSC | Human umbilical cord blood, Xenogenic | 150 μg/animal in 0.5 mL sterile PBS | Protein amount | DC | 0 h | IV | 7 days |
8 | Exosomes derived from human neural stem cells stimulated by interferon gamma improve therapeutic ability in ischemic stroke model | Zhang et al. (2020) China [29] | Rats | Sprague Dawley | Male | MCAO | NSC | Human fetal brain tissue, Xenogenic | 4 × 10^9 particles in 10 ul PBS/each rat) | Particle number | DC | 24 h after tMCAO | ICV | 28 days |
9 | Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke | Xia et al. (2020) China [30] | Rats | Sprague Dawley (SD) | Male | MCAO | IPS | ips, Xenogenic | 1 × 10^11 particles in 500 μL PBS | Particle number | DC | 4 h after tMCAO | IV | 28 days |
10 | Lithium modulates miR-1906 levels of mesenchymal stem cell-derived extracellular vesicles contributing to post-stroke neuroprotection by toll-like receptor 4 regulation | Haupt et al. (2020) Germany [31] | Mice | C57BL/6 | Male | MCAO | MSC | Bone marrow, Allogeneic | 13.5 μg 1\3\5 day | Protein amount | PEG | 1\3\5 day after MCAO | IV | 84 days |
11 | Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils | Wang et al. (2020) Germany [32] | Mice | C57BL6/j | Male | MCAO | MSC | Bone marrow, Xenogenic | 200 μL | Protein amount | PEG | 0 h | IV | 3 days |
12 | Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic–ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway | Hou et al. (2020) China [33] | Rats | Sprague Dawley (SD) | Male | MCAO | MSC | Bone marrow, Allogeneic | 100 μg/kg/day 3 days | Dosed by weight of animal | DC | 2 h MCAO | ICV | 3 days |
13 | Human placental mesenchymal stem cells improve stroke outcomes via extracellular vesicles-mediated preservation of cerebral blood flow | Barzegar et al. (2021) USA [34] | Mice | C57Bl/6 | Male | MCAO | MSC | Cholesterol treated placentas, Xenogenic | 2 × 10^6 in 100 ml HBSS | Particle number | DC | 1 h MCAO | IV | 1 day |
14 | Human umbilical cord mesenchymal stem cell-derived exosomal miR-146a-5p reduces microglial-mediated neuroinflammation via suppression of the IRAK1/TRAF6 signaling pathway after ischemic stroke | Zhang et al. (2021) China [35] | Mice | C57BL/6 | Not reported | MCAO | MSC | Umbilical cord mesenchymal stem cell, Xenogenic | 250 μL PBS with 50 μg | Protein amount | DC | 4 h after tMCAO | IV | 3 days |
15 | Dental pulp stem cell-derived exosomes alleviate cerebral ischemia–reperfusion injury through suppressing inflammatory response | Li et al. (2021) China [36] | Mice | C57BL/6 | Male | MCAO | MSC | Dental pulp, Xenogenic | 10 μg total protein per 100 μL PBS | Protein amount | DC | 2 h MCAO | ICV | 7 days |
16 | Upregulation of extracellular vesicles-encapsulated miR-132 released from mesenchymal stem cells attenuates ischemic neuronal injury by Inhibiting smad2/c-jun pathway via acvr2b suppression | Feng et al. (2021) China [37] | Mice | C57BL/6Â J | Male | MCAO | MSC | Bone marrow, Allogeneic | 200Â mg EVs | Protein amount | DC | 24Â h after tMCAO | IV | 1Â day |
17 | miR-31 from adipose stem cell-derived extracellular vesicles promotes recovery of neurological function after ischemic stroke by inhibiting TRAF6 and IRF5 | Lv et al. (2021) China [38] | Mice | C57BL/6 J | Male | MCAO | MSC | Adipose tissue, Allogeneic | 150 μg EVs | Protein amount | DC | 24 h after tMCAO | IV | 14 days |
18 | MiR-17–92 enriched exosomes derived from multipotent mesenchymal stromal cells enhance axon–myelin remodeling and motor electrophysiological recovery after stroke | Xin et al. (2021) USA [39] | Rats | Wistar | Male | MCAO | MSC | Bone marrow, Allogeneic | 3 × 10^11 particles | Particle number | DC | 24 h after MCAO | IV | 28 days |
19 | Embryonic stem cell-derived small extracellular vesicles modulate regulatory T cells to protect against ischemic stroke | Xia et al. (2021) China [40] | Mice | C57/BL6 | Male | MCAO | ESC | Human embryonic stem cells, Xenogenic | 10^9 particles in 200 μL of PBS | Particle number | DC | 0 h injected three times daily | IV | 28 days |
20 | Exosomal microRNA-22-3p alleviates cerebral ischemic injury by modulating KDM6B/BMP2/BMF axis | Zhang et al. (2021) China [41] | Rats | Sprague Dawley (SD) | Male | MCAO | MSC | Adipose tissue, Allogeneic | 100 μg/kg/day 3 days | Dosed by weight of animal | DC | Before the surgery | ICV | 3 days |
21 | microRNA-26a shuttled by extracellular vesicles secreted from adipose-derived mesenchymal stem cells reduce neuronal damage through KLF9-mediated regulation of TRAF2/KLF2 axis | Hou et al. (2021) China [42] | Mice | C57BL/6 | Male | MCAO | MSC | Adipose tissue, Allogeneic | 100Â mmol/kg/d,3Â days | Dosed by weight of animal | DC | Before the surgery | ICV | 3Â days |